UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 65.

A

Ali, K; Camps, M; Pearce, WP; Ji, H; Rückle, T; Kuehn, N; ... Vanhaesebroeck, B; + view all (2008) Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol , 180 (4) 2538 - 2544.

Alonzi, R.; (2008) Evaluation of the oxygenation and vascularity of prostate cancer using magnetic resonance imaging. Doctoral thesis, University of London. Green open access
file

Arkenau, H; Barrius, J; Olmos, D; Ang, JE; De Bono, J; Judson, I; Kaye, SB; (2008) Prospective validation of a prognostic score to improve patient selection for phase-1 trials. In: ANNALS OF ONCOLOGY. (pp. 145 - 145). OXFORD UNIV PRESS

Arkenau, H-T; Porschen, R; (2008) The combination of oxaliplatin with either capecitabine or infusional 5-fluorouracil/leucovorin results in comparable outcome in patients with metastatic colorectal cancer. American Journal of Hematology/ Oncology , 7 (1) 35 - 37.

AViolet, J; Dearling, JLJ; Green, AJ; Begent, RHJ; Pedley, RB; (2008) Fractionated I-131 anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice. BRIT J CANCER , 99 (4) 632 - 638. 10.1038/sj.bjc.6604511.

B

Barriuso, J; Arkenau, HT; Olmos, D; Ang, J; Brunetto, A; Frentzas, S; ... Kaye, S; + view all (2008) PROSPECTIVE VALIDATION OF A PROGNOSTIC SCORE FOR PATIENTS TREATED IN PHASE-I TRIALS. In: ANNALS OF ONCOLOGY. (pp. 164 - 164).

Besana, P; Patkar, V; Glasspool, D; Robertson, D; (2008) Distributed Workflows: The OpenKnowledge Experience. In: Meersman, R and Tari, Z and Herrero, P, (eds.) ON THE MOVE TO MEANINGFUL INTERNET SYSTEMS: OTM 2008 WORKSHOPS. (pp. 965 - 975). SPRINGER-VERLAG BERLIN

Bielack, S; Marina, N; Ferrari, S; Helman, LH; Smeland, S; Whelan, JS; Reaman, GH; (2008) Response to Meyers et al, Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival- a report from the Children's Oncology Group (letter0. Journal of Clinical Oncology , 4 633 - 638.

Bilanges, B; Torbett, N; Vanhaesebroeck, B; (2008) Killing two kinase families with one stone. Nat Chem Biol , 4 (11) 648 - 649. 10.1038/nchembio1108-648.

Brown, T; Mackay, H; Turlington, M; Sutterfield, A; Smith, T; Sielaff, A; ... and Lee, M; + view all (2008) Modifying the N-Terminus of Polyamides: PyImPyIm has Improved Sequence Specificity over f-ImPyIm. Bioorganic and Medicinal Chemistry , 16 5266 - 5276.

Buchler, T; Dubash, S; Lee, V; Chilton, D; Cartledge, J; Isaacson, P; ... Lee, SM; + view all (2008) Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman’s disease with multiorgan failure: report of two cases. AIDS , 22 (13) 1685 - 1687.

C

Calvert, H; Plummer, ER; Curtin, NJ; Edmondson, R; Drew, Y; (2008) PARP inhibitors in cancer treatment. In: EJC SUPPLEMENTS. (pp. 80 - 80). PERGAMON-ELSEVIER SCIENCE LTD

Cassoni, A; Ali, U; Cave, J; Edwards, SG; Ramsay, A; Miller, RF; Siow, ML; (2008) Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma. Journal of Clinical Oncology , 26 (32) 5297 - 5299. 10.1200/JCO.2008.18.3350.

Chen, YC; Chiang, HY; Yang, MH; Chen, PM; Chang, SY; Teng, SC; ... Wu, KJ; + view all (2008) Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif. J Mol Med (Berl) , 86 (4) 401 - 412. 10.1007/s00109-008-0302-x.

Chung, Y-L; Troy, H; Griffiths, JR; Kristeleit, R; Aherne, W; Judson, IR; ... Atadja, P; + view all (2008) Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts. Neoplasia , 10 (4) 303 - 313. 10.1593/neo.07834. Gold open access

D

Drew, Y; Calvert, H; (2008) The Potential of PARP Inhibitors in Genetic Breast and Ovarian Cancers. RECENT ADVANCES IN CLINICAL ONCOLOGY , 1138 136 - 145. 10.1196/annals.1414.020.

F

Fern, L; Campbell, C; Eden, T; Grant, R; lewis, I; McCleod, U; ... J,; + view all (2008) Addressing delayed cancer diagnosis in primary care: Patterns of attendance and symptoms of teenagers and young adults seen in 3 general practices during 1 year. In: National Cancer Research Institute Cancer Conference, 2008, Birmingham.

Fidarova, EF; El-Emir, E; Boxer, GM; Qureshi, U; Robson, MP; Dearling, JLJ; ... Pedley, RB; + view all (2008) Microdistribution of targeted, fluorescently-labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy. Clinical Cancer Research , 14 2639 - 2646.

Fox, J; Black, E; Chronakis, I; Dunlop, R; Patkar, V; South, M; Thomson, R; (2008) From guidelines to careflows: modelling and supporting complex clinical processes. Stud Health Technol Inform , 139 44 - 62.

G

Gaya, AM; Violet, J; Dancey, G; Green, A; Stratford, M; Sharma, S; ... Meyer, T; + view all (2008) A phase I/II trial of radioimmunotherapy with (131)Iodine labelled A5B7 anti-CEA antibody (I-131-A5B7) in combination with Combretastatin-A4-Phosphate (CA4P) in advanced gastrointestinal carcinomas. In: JOURNAL OF CLINICAL ONCOLOGY.

Gelderblom, H; Sydes, MR; Morgan, RC; Hogendoorn, PC; Lewis, IJ; Nooij, MA; ... Whelan, J; + view all (2008) Survival after recurrent osteosarcoma: Data from three European Osteosarcoma Intergroup (EOI) randomized controlled. In: JOURNAL OF CLINICAL ONCOLOGY.

Guillermet-Guibert, J; Bjorklof, K; Salpekar, A; Gonella, C; Ramadani, F; Bilancio, A; ... Vanhaesebroeck, B; + view all (2008) The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci U S A , 105 (24) 8292 - 8297. 10.1073/pnas.0707761105.

Guo, H; Samarakoon, A; Vanhaesebroeck, B; Malarkannan, S; (2008) The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J Exp Med , 205 (10) 2419 - 2435. 10.1084/jem.20072327.

H

Hochhauser, D; Meyer, T; Loadman, P; Spanswick, VJ; Cobb, M; Begent, RH; ... Jodrell, D; + view all (2008) Phase I study of the DNA minor groove binding pyrrolobenzodiazepine dimer (SJG 136) administered every 21 days in patients with advanced solid tumours. In: JOURNAL OF CLINICAL ONCOLOGY.

Howie, AJ; (2008) Handbook of renal biopsy pathology. (2nd ed. ed.). Springer: New York, USA.

K

Krishnamoorthy, N; Oriss, TB; Paglia, M; Fei, M; Yarlagadda, M; Vanhaesebroeck, B; ... Ray, P; + view all (2008) Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med , 14 (5) 565 - 573. 10.1038/nm1766.

L

Lee, SM; Brada, M; Stenning, S; Thompson, L; (2008) A randomised trial of Procarbazine, CCNU and Vincristine (PCV) vs Temozolomide (5-day or 21-day schedule) for recurrent high grade glioma (MRC BR12, ISRCTN83176944). In: (Proceedings) Presidential Symposium. 33rd ESMO Congress Stockholm, Sweden.

Lee, SM; Buchler, T; Grant, H; Lai, C; (2008) Bilateral eardrum perforation after long-term treatment with erlotinib. Journal of Clinical Oncology , 26 (15) 2582 - 2584.

Lee, SM; James, L; Buchler, T; Snee, M; Ellis, P; Hackshaw, A; (2008) Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer. Lung Cancer , 59 (3) 364 - 368.

Lee, SM; James, L; Buchler, T; Snee, M; Ellis, P; Hackshaw, A; (2008) Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer. Lung Cancer , 59 (3) 364 - 368. 10.1016/j.lungcan.2007.08.032.

Lee, SM; Rudd, RM; Woll, PJ; Ottensmeier, CH; James, LE; Gower, NH; ... Hackshaw, A; + view all (2008) Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In: (Proceedings) 2008 ASCO Annual Meeting Proceedings, Chicago, IL. (pp. 435s - ?). Journal of Clinical Oncology

M

Mackay, H; Brown, T; Sexton, JS; Kotecha, M; Nguyen, B; Wilson, WD; ... Hartley, JA; + view all (2008) Targeting the inverted CCAAT Box-2 of the topoisomerase II alpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimer. BIOORGAN MED CHEM , 16 (4) 2093 - 2102. 10.1016/j.bmc.2007.10.059.

Marina, N; Bielack,; S,; Whelan, JS; Smeland, S; Krailo, M; ... Bernstein, M; + view all (2008) UNSPECIFIED In: (Proceedings) International collaboration is feasible for trials in rare conditions: the EURAMOS experience. Meeting Proceedings - Paediatric and Adolescent Osteosarcoma. Progress from the past, prospects for the future.. : Houston.

McTiernan, A; Morgan, R; Sydes, MR; Uscinska, B; van, GM; Bramwell, V; ... Whelan, JS; + view all (2008) The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup. In: CTOS, London Nov 2008.

Meyer, T; Caplin, M; Palmer, D; Valle, JW; Larvin, M; Waters, J; ... Kato, H; + view all (2008) A phase IB/IIA, multicentre, randomised, double-blind placebo controlled study to evaluate the safety and pharmacokinetics of Z-360 in subjects with unresectable advanced pancreatic cancer in combination with gemcitabine. JOURNAL OF CLINICAL ONCOLOGY , 26 (15)

N

Ng, Q.S.; (2008) Therapeutic targeting and clinical assessment of the tumour vasculature. Doctoral thesis, University of London. Green open access
file

O

Olmos, D; Arkenau, H-T; Ang, JE; de Bono, JS; Judson, I; Kaye, SB; (2008) Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience. BRITISH JOURNAL OF CANCER , 99 (8) 1365 - 1365. 10.1038/sj.bjc.6604649.

P

Papakonstanti, EA; Zwaenepoel, O; Bilancio, A; Burns, E; Nock, GE; Houseman, B; ... Vanhaesebroeck, B; + view all (2008) Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. J Cell Sci , 121 (Pt 24) 4124 - 4133. 10.1242/jcs.032763.

Patkar, V; Fox, J; (2008) Clinical guidelines and care pathways: a case study applying PROforma decision support technology to the breast cancer care pathway. Stud Health Technol Inform , 139 233 - 242.

Paulussen, M; Craft, A; Lewis, I; Hackshaw, A; Douglas, C; Dunst, J; ... Jurgens, HFTEICESSG; + view all (2008) Results of the EICESS-92 study: two randomised trials of Ewing's sarcoma treatment. Journal of Clinical Oncology , 20 4385 - 4393.

Pedley, RB; Qureshi U, E-EE; Fidarova E, BG; Robson M, DF; (2008) OXi4503 shows efficacy as a single agent in colorectal liver metastases in nude mice, and potential for enhancing antibody-targeted therapies. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 188 - ?).

Pillai, RG; Forster, M; Perumal, M; Mitchell, F; Leyton, J; Aibgirhio, FI; ... Aboagye, EO; + view all (2008) Imaging pharmacodynamics of the alpha-folate receptor-targeted thymidylate synthase inhibitor BGC 945. Cancer Res , 68 (10) 3827 - 3834. 10.1158/0008-5472.CAN-08-0135.

Postel-Vinay, S; Arkenau, HT; Olmos, D; Barriuso, J; Ashley, S; Ang, J; ... Kaye, S; + view all (2008) Patient selection criteria for PHASE-I trials in oncology: Low lymphocyte counts are associated with poor survival. In: ANNALS OF ONCOLOGY. (pp. 34 - 35).

Puzanov, I; Lee, W; Berlin, JD; Calcutt, MW; Hachey, DL; Vermeulen, WL; ... Rothenberg, ML; + view all (2008) Final results of phase I and pharmacokinetic trial of SJG-136 administered on a daily x 3 schedule. In: JOURNAL OF CLINICAL ONCOLOGY.

R

Rajkumar, V; Robson, M; Boxer, G; Begent, RHJ; Pedley, RB; (2008) Imatinib mesylate augments the selective targeting to tumour of radiolabeled anti-CEA antibodies from non-tumour tissues in LS174T and SW1222 xenografts. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 188 - ?).

Rajkumar, V; Robson, M; Boxer, G; Begent, RHJ; Pedley, RB; (2008) Imatinib mesylate delays tumour regrowth after single dose CA-1-P therapy in LS174T but not SW1222 xenografts. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 188 - ?).

Ray-Coquard, I; Le, CA; Whelan, JS; Scoffski, P; Bui, BN; Verweij, J; ... Blay, J-Y; + view all (2008) A phase II study of Gefitinib for patients with HER-1 expressing advanced synovial sarcoma refractory to doxorubicin-based chemotherapy. The Oncologist , 13 467 - 473.

S

Sarker, D; Anderson, D; Spanswick, VJ; Davies, S; Agarwal, R; Aitken, G; ... Middleton, MR; + view all (2008) Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide). In: JOURNAL OF CLINICAL ONCOLOGY.

Short, S; C,; (2008) Survival from brain tumours in England and Wales up to 2001. British Journal of Cancer

Short, SC; Martindale, C; Worku, M; Bourne, S; (2008) THE INFLUENCE OF RAD51 MEDIATED REPAIR ON TREATMENT RESISTANCE IN HIGH-GRADE GLIOMAS. In: NEURO-ONCOLOGY. (pp. 1144 - 1144).

Sky, NO; (2008) EMEA Likely To Give Go Ahead On Thalidomide. UNSPECIFIED

Soria, SC; Plummer, R; Soto, A; Massard, C; Calvert, H; Prados, R; ... de las Heras, B; + view all (2008) Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma. In: EJC SUPPLEMENTS. (pp. 57 - 57). PERGAMON-ELSEVIER SCIENCE LTD

Stebbing, J; Harrison, M; Glynne-Jones, R; Bridgewater, J; Propper, D; (2008) A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study). Br J Cancer , 98 (4) 716 - 719. 10.1038/sj.bjc.6604232.

T

Taylor, RE; Pizer, BL; Short, S; (2008) Promoting Collaboration between Adult and Paediatric Clinical Trial Groups. Clinical Oncology , 20 (9) 714 - 716. 10.1016/j.clon.2008.06.009.

Tiberghien, AC; Evans, DA; Kiakos, K; Martin, CRH; Hartley, JA; Thurston, DE; Howard, PW; (2008) An asymmetric C8/C8'-tripyrrole-llinked sequence-selective Pyrrolo[2,1-c]]1,4]benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs. Bioorganic and Medicinal Chemistry Letters , 18 (6) 2073 - 2077. 10.1016/j.bmcl.2008.01.096.

V

Vergote, IB; Calvert, H; Kania, M; Zimmerman, A; Look, K; Sehouli, J; (2008) A randomized phase II study of standard-versus high-dose pernetrexed in platinum-resistant epithellial ovarian cancer. GYNECOL ONCOL , 108 (3) S113 - S113.

Violet, JA; Dearling, JLJ; Green, AJ; Begent, RHJ; Pedley, RB; (2008) Effects on xenograft tumour growth and haematological toxicity in mice. British Journal of Cancer , 99 632 - 638.

W

Whelan, J; Fern, L; (2008) Keynote Comment: Poor rates of accrual of teenagers and young adults into clinical trials in the UK. The Lancet Oncology , 9 306 - 307.

Whelan, J; Fern, LA; (2008) Rates of inclusion of teenagers and young adults (TYA) with cancer into UK National Cancer Research Institute (NCRI) clinical trials, 2005-2007. In: JOURNAL OF CLINICAL ONCOLOGY.

Whelan, J; Sydes, M; Bielack, S; Sigbjorn, S; Marina, N; May, B; ... Bernstein, M; + view all (2008) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma:EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT EUROCORES) - a potential model for collaboration in rare diseases. In: British Sarcoma Group meeting 2008 conference abstracts.

Whelan, JS; Fern, LA; (2008) Poor accrual of teenagers and young adults into clinical trials in the UK. Lancet Oncol , 9 (4) 306 - 307. 10.1016/S1470-2045(08)70080-9.

Whelan, JS; McTiernan, A; Morgan, R; Sydes, MR; Souhami, RL; Bramwell, V; ... Taminiau, A; + view all (2008) Mature results of 1067 patients treated in three European Osteosarcoma Intergroup randomised studies. In: CTOS, London Nov 2008.

Wilkinson, SJ; Kucukmetin, A; Cross, P; Darby, S; Gnanapragasam, VJ; Calvert, AH; ... Edmondson, RJ; + view all (2008) Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer. HUM PATHOL , 39 (8) 1197 - 1204. 10.1016/j.humpath.2007.12.011.

Z

Zhang, EZ; Laufer, J; Pedley, RB; Beard, P; (2008) 3D photoacoustic imaging system for in vivo studies of small animal models - art. no. 68560P. In: Oraevsky, AA and Wang, LV, (eds.) PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2008: THE NINTH CONFERENCE ON BIOMEDICAL THERMOACOUSTICS, OPTOACOUSTICS, AND ACOUSTIC-OPTICS. (pp. P8560 - P8560). SPIE-INT SOC OPTICAL ENGINEERING

Zhang, TT; Okkenhaug, K; Nashed, BF; Puri, KD; Knight, ZA; Shokat, KM; ... Marshall, AJ; + view all (2008) Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol , 122 (4) 811 - 819.e2. 10.1016/j.jaci.2008.08.008.

This list was generated on Sun Dec 21 23:57:29 2014 GMT.